Cincor Pharma Inc (CINC) PT Raised to $60 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CINC Hot Sheet
Price: $29.06 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung raised the price target on Cincor Pharma Inc (NASDAQ: CINC) to $60.00 (from $45.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Goldman Sachs Upgrades Plains All American (PAA) to Neutral
- Abivax (ABVX) PT Lowered to $136 at Wolfe Research
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
